<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
<html>
<head>
<title></title>
</head>
<body link="#0000ff" vlink="#7f007f">
<p align="CENTER"><b><font size="5">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
</font>Washington, D.C. 20549</b></p>

<p align="CENTER"><b><font size="5">FORM 8-K</font></b></p>

<p align="CENTER"><b><font size="5">CURRENT REPORT</font><br>
</b>__________________________________________</p>

<p align="CENTER">Pursuant to Section 13 or 15 (d) of<br>
The Securities Exchange Act of 1934</p>

<p align="CENTER"><b>December 7, 2007</b><br>
Date of report (date of earliest event reported)</p>

<p align="CENTER"><b><u><font size=
"5">&nbsp;&nbsp;&nbsp;&nbsp;FOREST LABORATORIES,
INC.&nbsp;&nbsp;&nbsp;&nbsp;<br>
</font></u></b> (Exact name of registrant as specified in its
charter)</p>

<center>
<table cellspacing="0" border="0" width="562">
<tr>
<td width="44%" valign="TOP">
<p align="CENTER"><b>Delaware<br>
</b><i>(State or other jurisdiction of<br>
incorporation or organization)</i></p>
</td>
<td width="18%" valign="TOP">
<p align="CENTER"><b>1-5438<br>
</b>(Commission<br>
 File Number)</p>
</td>
<td width="38%" valign="TOP">
<p align="CENTER"><b>11-1798614<br>
</b><i>(I.R.S. Employer<br>
Identification Number)</i></p>
</td>
</tr>

<tr>
<td width="44%" valign="TOP">&nbsp;</td>
<td width="18%" valign="TOP">&nbsp;</td>
<td width="38%" valign="TOP">&nbsp;</td>
</tr>

<tr>
<td width="44%" valign="TOP">
<p align="CENTER"><b>909 Third Avenue<br>
New York, New York<br>
</b> <i>(Address of principal executive offices)</i></p>
</td>
<td width="18%" valign="TOP">
<p>&nbsp;</p>
</td>
<td width="38%" valign="TOP">
<p align="CENTER"><b>10022-4731<br>
</b><i>(Zip code)</i></p>
</td>
</tr>
</table>
</center>

<p align="CENTER"><b>(212) 421-7850<br>
</b><i>(Registrant's telephone number, including area code)</i>
<u><br>
<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>

</u> <i>(Former name or former address, if changed since last
report)<br>
</i></p>

<p><i>Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:</i></p>

<p><font size="3">[&nbsp;]&nbsp;&nbsp;Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>
[&nbsp;]&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)<br>
[&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))<br>
[&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<i><br>
</i></font></p>

<p align="JUSTIFY">&nbsp;</p>

<p><b>Item 1.01. <u>Entry into a Material Definitive
Agreement</u></b></p>

<p align="JUSTIFY"><b><u><font size="3">Loan
Agreement</font></u></b></p>

<p><a name="id_0_5"></a><a name="id_0_6"></a>On December 7,
2007, Forest Laboratories, Inc. (the "Company"), certain of the
Company&rsquo;s foreign subsidiaries (the "Borrowing
Subsidiaries"), the lenders party thereto (the "Lenders"), and
JPMorgan Chase Bank, N.A. (the "Agent"), as administrative agent,
entered into a Credit Agreement (the "Credit Agreement") providing
to the Company and the Borrowing Subsidiaries an unsecured,
revolving credit facility for up to $500,000,000, which may be
increased by up to an additional $250,000,000 (as either additional
revolving or new term loans) at the election of the Company
pursuant to arrangements with Lenders or new parties and subject to
certain conditions. The Credit Agreement will terminate in
accordance with its terms on December 7, 2012 subject to earlier
termination upon fulfillment of certain terms and
conditions.</p>

<p>The Credit Agreement contains customary representations,
warranties and covenants, including a covenant that the leverage
ratio of the Company be at all times less than or equal to
3.00:1.00 on a rolling four fiscal quarter basis. The leverage
ratio is the ratio of Consolidated Total Indebtedness to
Consolidated EBITDA (as each term is defined in the Agreement).
Loans under the Agreement bear interest at a variable rate based on
the Company&rsquo;s leverage ratio.</p>

<p>The Company intends to use the proceeds from loans under the
Agreement to support the Company&rsquo;s growth strategy through
the financing of the Company&rsquo;s working capital needs and
general corporate purposes, including but not limited to product
and other acquisitions. To date, the Company has not drawn on the
new credit facility. J.P. Morgan Securities Inc. was the sole book
runner and lead arranger for the Credit Agreement.</p>

<p>This description of the Credit Agreement is qualified in its
entirety by reference to the Agreement filed herewith as Exhibit
10.1.</p>

<p align="JUSTIFY"><b>Item 2.03</b> &nbsp;<b>Creation of a Direct
Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant</b></p>

<p>As described under Item 1.01 above, on December 7, 2007, the
Company entered into the Credit Agreement providing for a
$500,000,000 revolving credit facility. Upon the occurrence of
certain events, including, but not limited to, the Company&rsquo;s
failure to make required payments under the Credit Agreement or the
Company&rsquo;s default in its other obligations under the Credit
Agreement, the Agent may take certain remedial actions, including,
but not limited to, terminating the Credit Agreement and declaring
all unpaid principal, unpaid interest and all other fees and
obligations thereunder immediately due.</p>

<p>This description of the Agreement is qualified in its entirety
by reference to the Agreement filed herewith as Exhibit 10.1.</p>

<p><b>Item 9.01. <u>Financial Statements and Exhibits</u></b></p>

<p>(d)&nbsp;&nbsp;Exhibits:</p>

<table cellspacing="0" border="0" cellpadding="7" width="642">
<tr>
<td width="7%" valign="TOP">&nbsp;</td>
<td width="20%" valign="TOP">
<p><u>Exhibit Number</u></p>
</td>
<td width="74%" valign="TOP">
<p>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>
Exhibit</u></p>
</td>
</tr>

<tr>
<td width="7%" valign="TOP">&nbsp;</td>
<td width="20%" valign="TOP">
<p>10.1</p>
</td>
<td width="74%" valign="TOP">
<p>Credit Agreement, dated December 7, 2007, by and among Forest
Laboratories, Inc., Forest Laboratories Holdings Limited, Forest
Laboratories Ireland Limited, Forest Finance B.V., Forest
Laboratories UK Limited, the lenders party thereto, and JPMorgan
Chase Bank, N.A.</p>
</td>
</tr>
</table>

<p align="CENTER"><font face="Courier"><a name=
"Quick_Links"></a></font></p>

<p align="CENTER"><a name="STATEMENTS_OF_INCOME"></a>
SIGNATURES</p>

<p align="JUSTIFY">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly
authorized.</p>

<p align="JUSTIFY">Date: December 11, 2007</p>

<p align="JUSTIFY"><br>
<br>
</p>

<blockquote>
<div style="margin-left: 10em">
<p><u>Forest Laboratories, Inc.</u><br>
(Registrant)</p>

<p align="JUSTIFY"><br>
</p>

<p><u>/s/ Howard
Solomon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>

</u> Howard Solomon<br>
Chairman of the Board and<br>
Chief Executive Officer</p>
</div>
</blockquote>

<p><a name="STATEMENTS_OF_COMPREHENSIVE_INCOME"></a></p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<table cellspacing="0" border="0" cellpadding="7" width="672">
<tr>
<td valign="TOP" colspan="3">
<p align="CENTER">EXHIBIT INDEX<br>
</p>
</td>
</tr>

<tr>
<td width="12%" valign="TOP">&nbsp;</td>
<td width="19%" valign="TOP">
<p><u>Exhibit Number</u></p>
</td>
<td width="70%" valign="TOP">
<p>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>
Exhibit</u></p>
</td>
</tr>

<tr>
<td width="12%" valign="TOP">&nbsp;</td>
<td width="19%" valign="TOP">
<p>10.1</p>
</td>
<td width="70%" valign="TOP">
<p>Credit Agreement, dated December 7, 2007, by and among Forest
Laboratories, Inc., Forest Laboratories Holdings Limited, Forest
Laboratories Ireland Limited, Forest Finance B.V., Forest
Laboratories UK Limited, the lenders party thereto, and JPMorgan
Chase Bank, N.A.</p>
</td>
</tr>
</table>

<p align="RIGHT"><font face="Courier">&nbsp;</font></p>
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "forest8kdec07.htm", "description": "FOREST LABORATORIES, INC. 8-K", "secsgml_size_bytes": 8912}]
{"company-data": {"conformed-name": "FOREST LABORATORIES INC", "cik": "0000038074", "assigned-sic": "2834", "irs-number": "111798614", "state-of-incorporation": "DE", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-05438", "film-number": "071304447"}, "business-address": {"street1": "909 THIRD AVENUE", "city": "NEW YORK", "state": "NY", "zip": "10022", "phone": "(212)421-7850"}, "mail-address": {"street1": "909 THIRD AVENUE", "city": "NEW YORK", "state": "NY", "zip": "10022"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
__________________________________________
Pursuant to Section 13 or 15 (d) of
The Securities Exchange Act of 1934
December 7, 2007
Date of report (date of earliest event reported)
FOREST LABORATORIES,
INC.
(Exact name of registrant as specified in its
charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
1-5438
(Commission
File Number)
11-1798614
(I.R.S. Employer
Identification Number)
909 Third Avenue
New York, New York
(Address of principal executive offices)
10022-4731
(Zip code)
(212) 421-7850
(Registrant's telephone number, including area code)
None
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
[ ]  Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]  Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
[ ]  Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))
[ ]  Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.
Entry into a Material Definitive
Agreement
Loan
Agreement
On December 7,
2007, Forest Laboratories, Inc. (the "Company"), certain of the
Company's foreign subsidiaries (the "Borrowing
Subsidiaries"), the lenders party thereto (the "Lenders"), and
JPMorgan Chase Bank, N.A. (the "Agent"), as administrative agent,
entered into a Credit Agreement (the "Credit Agreement") providing
to the Company and the Borrowing Subsidiaries an unsecured,
revolving credit facility for up to $500,000,000, which may be
increased by up to an additional $250,000,000 (as either additional
revolving or new term loans) at the election of the Company
pursuant to arrangements with Lenders or new parties and subject to
certain conditions. The Credit Agreement will terminate in
accordance with its terms on December 7, 2012 subject to earlier
termination upon fulfillment of certain terms and
conditions.
The Credit Agreement contains customary representations,
warranties and covenants, including a covenant that the leverage
ratio of the Company be at all times less than or equal to
3.00:1.00 on a rolling four fiscal quarter basis. The leverage
ratio is the ratio of Consolidated Total Indebtedness to
Consolidated EBITDA (as each term is defined in the Agreement).
Loans under the Agreement bear interest at a variable rate based on
the Company's leverage ratio.
The Company intends to use the proceeds from loans under the
Agreement to support the Company's growth strategy through
the financing of the Company's working capital needs and
general corporate purposes, including but not limited to product
and other acquisitions. To date, the Company has not drawn on the
new credit facility. J.P. Morgan Securities Inc. was the sole book
runner and lead arranger for the Credit Agreement.
This description of the Credit Agreement is qualified in its
entirety by reference to the Agreement filed herewith as Exhibit
10.1.
Item 2.03
Creation of a Direct
Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant
As described under Item 1.01 above, on December 7, 2007, the
Company entered into the Credit Agreement providing for a
$500,000,000 revolving credit facility. Upon the occurrence of
certain events, including, but not limited to, the Company's
failure to make required payments under the Credit Agreement or the
Company's default in its other obligations under the Credit
Agreement, the Agent may take certain remedial actions, including,
but not limited to, terminating the Credit Agreement and declaring
all unpaid principal, unpaid interest and all other fees and
obligations thereunder immediately due.
This description of the Agreement is qualified in its entirety
by reference to the Agreement filed herewith as Exhibit 10.1.
Item 9.01.
Financial Statements and Exhibits
(d)  Exhibits:
Exhibit Number
Exhibit
10.1
Credit Agreement, dated December 7, 2007, by and among Forest
Laboratories, Inc., Forest Laboratories Holdings Limited, Forest
Laboratories Ireland Limited, Forest Finance B.V., Forest
Laboratories UK Limited, the lenders party thereto, and JPMorgan
Chase Bank, N.A.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly
authorized.
Date: December 11, 2007
Forest Laboratories, Inc.
(Registrant)
/s/ Howard
Solomon
Howard Solomon
Chairman of the Board and
Chief Executive Officer
EXHIBIT INDEX
Exhibit Number
Exhibit
10.1
Credit Agreement, dated December 7, 2007, by and among Forest
Laboratories, Inc., Forest Laboratories Holdings Limited, Forest
Laboratories Ireland Limited, Forest Finance B.V., Forest
Laboratories UK Limited, the lenders party thereto, and JPMorgan
Chase Bank, N.A.